Análisis Argos
HQY
HQYCara
HealthEquity, Inc. · Healthcare
US$ 101.24
precio al 2026-07-28
Valor justo Argos*
US$ 51–56
vs. su valor justo
80% por encima
Score Argos
57/100
LA RESPUESTA
El mercado le pide crezca 29.9% al año — más de lo que ha demostrado (10.3%). Estás pagando un futuro que todavía no probó: el margen de error es mínimo.
Recompensas
✓Las ganancias crecieron 123% el último año.
Riesgos
!El precio pide más crecimiento del que la empresa ha demostrado.
!Venta significativa de insiders en el último trimestre.
VALOR1/6FUTURO4/6PASADO4/6SALUD3/6DIVIDENDO4/6
El Iris de calidad
VALOR1/6FUTURO4/6PASADO4/6SALUD3/6DIVIDENDO4/6
ValorCotiza por encima de su valor justo
FuturoIngresos creciendo con fuerza
PasadoFundamentales sólidos y sostenidos
SaludBalance razonable
DividendoDevuelve capital al accionista
Score Argos57de 100Cara
Ingresos▲9%
US$ 1.3 B
Margen operativo▲28%
24.6%
Flujo de caja libre▲35%
US$ 0.5 B
Deuda neta
US$ 0.7 B
Lo esencial, sin ruido
Cap. de mercadoUS$ 8.5B
P/E39.3x
EV/EBITDA19.2x
FCF yield5.4%
ROIC9%
Margen operativo24.6%
Crecim. ingresos+9.5%/año
Piotroski F9/9
Competidores

Los rivales, con el mismo ojo

El Iris de calidad de cada competidor, lado a lado. Tocá uno para ver su análisis.

Novedades

Noticias recientes

zacks.com · 16 jul
Reasons to Hold HealthEquity Stock in Your Portfolio for Now
HQY benefits from strong HSA growth, AI-driven automation and solid first-quarter fiscal 2027 results despite data security risks.
zacks.com · 13 jul
Here's Why HealthEquity (HQY) is a Strong Momentum Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
zacks.com · 8 jul
GDRX or HQY: Which Is the Better Value Stock Right Now?
Investors interested in Medical Services stocks are likely familiar with GoodRx Holdings, Inc. (GDRX) and HealthEquity (HQY). But which of these two stocks offers value investors a better bang for their buck right now?
zacks.com · 6 jul
Here's Why HealthEquity (HQY) is a Strong Growth Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
zacks.com · 19 jun
Here's Why HealthEquity (HQY) is a Strong Growth Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
zacks.com · 12 jun
Reasons to Hold HealthEquity Stock in Your Portfolio for Now
HQY benefits from strong HSA growth, AI-driven automation and solid first-quarter fiscal 2027 results despite data security risks.
zacks.com · 11 jun
Is HealthEquity's Improving Profitability Enough to Offset Key Risks?
HQY raises fiscal 2027 guidance after strong Q1 results, but custodial yield swings and cybersecurity worries remain.
globenewswire.com · 8 jun
One in Three Americans Delay Medical Care Due to Cost, HealthEquity Research Finds
Healthcare Cost Pressures Drive Workplace Productivity Losses; HSA Holders Report Stronger Confidence and Control Healthcare Cost Pressures Drive Workplace Productivity Losses; HSA Holders Report Stronger Confidence and Control

* Valor justo Argos: estimación educativa del valor intrínseco según el propio flujo de caja de la empresa y su capacidad de crecimiento — no un precio objetivo ni una recomendación. Esto es información y educación, no asesoría de inversión. Rendimiento pasado no garantiza resultados futuros.